From wortmannin and LY 294002 : the path towards clinical candidates for PI 3 K inhibition


In contrast with cytotoxic agents that do not differentiate between normal proliferating and tumour cells, targeted therapies primarily exert their actions in cancer cells. Initiation and maintenance of tumours are due to genetic alterations in specific loci. The identification of the genes in which these alterations occur has opened new opportunities for… (More)

3 Figures and Tables


  • Blog articles referencing this paper

  • Presentations referencing similar topics